Outdoor light at night could be a significant risk factor in Alzheimer's disease, according to new research from Rush.
Vous n'êtes pas connecté
Lecanemab could be the ‘beginning of the end’ for the disease, experts suggest.
Outdoor light at night could be a significant risk factor in Alzheimer's disease, according to new research from Rush.
FRIDAY, Sept. 6, 2024 -- People who live in areas with more nighttime light pollution could be at increased risk of Alzheimer’s disease,...
THURSDAY, Sept. 11, 2024 -- Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab (Leqembi) and donanemab (Kisunla), have been...
A team of researchers in Japan has discovered a potential new way to treat Alzheimer’s disease using dopamine, a chemical naturally produced in the...
A team of researchers in Japan has discovered a potential new way to treat Alzheimer’s disease using dopamine, a chemical naturally produced in the...
New research has found a way to diagnose Alzheimer’s disease (AD) earlier by analyzing biomarkers in blood. This could help reduce the effects of...
Does the West really want Ukraine to win? Can Ukraine finally use the British Storm Shadow missiles? Why is the U.S. hesitating to give permission...
Alzheimer’s disease is one of the leading causes of memory loss and confusion in older people worldwide. It is also the most common type of brain...
New research from the University of Kentucky’s Sanders-Brown Center on Aging has revealed that the cognitive impairments seen in long COVID patients...
Researchers from DARPA and Harvard are exploring how an Alzheimer's drug could be used to save lives in emergency situations.